| dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
| dc.contributor.author | Mansouri, Larry |
| dc.contributor.author | Thorvaldsdottir, Birna |
| dc.contributor.author | Sutton, Lesley-Ann |
| dc.contributor.author | KARAKATSOULIS, GEORGIOS |
| dc.contributor.author | Meggendorfer, Manja |
| dc.contributor.author | Parker, Helen |
| dc.contributor.author | Bosch, Francesc |
| dc.contributor.author | Tazon-Vega, Barbara |
| dc.date.accessioned | 2023-05-11T07:24:49Z |
| dc.date.available | 2023-05-11T07:24:49Z |
| dc.date.issued | 2023-02 |
| dc.identifier.citation | Mansouri L, Thorvaldsdottir B, Sutton LA, Karakatsoulis G, Meggendorfer M, Parker H, et al. Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY. Leukemia. 2023 Feb;37(2):339–47. |
| dc.identifier.issn | 1476-5551 |
| dc.identifier.uri | https://hdl.handle.net/11351/9508 |
| dc.description | Genética del cáncer; Investigación genética |
| dc.language.iso | eng |
| dc.publisher | Springer Nature |
| dc.relation.ispartofseries | Leukemia;37(2) |
| dc.rights | Attribution 4.0 International |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
| dc.source | Scientia |
| dc.subject | Leucèmia limfocítica crònica - Aspectes genètics |
| dc.subject | Anomalies cromosòmiques |
| dc.subject.mesh | Leukemia, Lymphocytic, Chronic, B-Cell |
| dc.subject.mesh | /genetics |
| dc.subject.mesh | Mutation |
| dc.title | Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY |
| dc.type | info:eu-repo/semantics/article |
| dc.identifier.doi | 10.1038/s41375-022-01802-y |
| dc.subject.decs | leucemia linfocítica crónica de células B |
| dc.subject.decs | /genética |
| dc.subject.decs | mutación |
| dc.relation.publishversion | https://doi.org/10.1038/s41375-022-01802-y |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.contributor.organismes | Institut Català de la Salut |
| dc.contributor.authoraffiliation | [Mansouri L, Thorvaldsdottir B, Sutton LA] Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. [Karakatsoulis G] Centre for Research and Technology Hellas, Institute of Applied Biosciences, Thessaloniki, Greece. Department of Mathematics, University of Ioannina, Ioannina, Greece. [Meggendorfer M] MLL Munich Leukemia Laboratory, Munich, Germany. [Parker H] Cancer Genomics, School for Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK. [Bosch F, Tazón-Vega B] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain |
| dc.identifier.pmid | 36566271 |
| dc.identifier.wos | 000920775400001 |
| dc.relation.projectid | info:eu-repo/grantAgreement/EC/H2020/739593 |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess |